PhI p 12

What is PhI p 12 and what is its biochemical classification?

PhI p 12 is a profilin protein derived from timothy grass (Phleum pratense) pollen. It is classified as a minor grass pollen allergen with significant cross-reactivity properties. In allergen nomenclature, "Phl" refers to the genus Phleum, "p" indicates pollen origin, and "12" is its numerical designation within the species allergens. It is also known by several synonyms including Profilin-1, Allergen Phl p 11, Pollen allergen Phl p 12, and PHLPXI .

Methodologically, researchers should note that PhI p 12 functions in cytoskeleton mobility by interacting with actin filaments, making it a crucial target for understanding molecular mechanisms of cross-reactivity between pollen allergens and plant food allergens .

What are the structural and physical characteristics of PhI p 12?

PhI p 12 is a glycosylated polypeptide chain with a calculated molecular mass of 15,607 Dalton. When produced recombinantly (such as in Sf9 insect cells), it is typically expressed with a 10xHis tag at the N-terminus for purification purposes .

For experimental applications, researchers should note that:

• Physical appearance: Purified PhI p 12 appears as a sterile filtered clear solution

• Formulation: It is typically supplied in 20mM HEPES buffer pH-7.9 and 6M Urea

• Stability considerations: Store at 4°C if using within 2-4 weeks, or at -20°C for longer periods

• Purity assessment: >80.0% as determined by SDS-PAGE

• Critical handling note: Multiple freeze-thaw cycles should be avoided to maintain structural and functional integrity

How does PhI p 12 interact with the human immune system?

PhI p 12 engages with the human immune system through multiple pathways that contribute to its allergenicity:

• Antibody interactions: PhI p 12 binds IgE-type human antibodies, a critical step in triggering allergic responses .

• T-cell activation: Research demonstrates that PhI p 12 elicits strong and frequent T-cell responses in profilin-sensitized patients. Surprisingly, both the frequency (17/26 studied donors) and strength of T-cell responses to PhI p 12 were comparable to those against the major allergen Phl p 1, despite PhI p 12 being classified as a minor allergen .

• Cross-reactivity mechanisms: Due to high sequence homology among plant profilins, PhI p 12 demonstrates extensive cross-reactivity with profilins from other pollens (e.g., Bet v 2 from birch) and plant foods, potentially triggering pollen-food syndrome in sensitized individuals .

What is known about PhI p 12 prevalence in allergic populations?

The prevalence of PhI p 12 sensitization varies significantly based on geographical location and primary sensitization pathway:

• Geographical gradient: A clear north-south gradient exists in profilin sensitization rates across Europe, ranging from approximately 5% in Swedish birch pollen-allergic populations to as high as 51% in Spanish populations allergic to Mercurialis annua .

• Primary sensitization considerations: When analyzing prevalence data, it is methodologically critical to distinguish whether study populations were selected based on pollen allergy or plant food allergy as the primary criterion, as this significantly impacts reported sensitization rates .

• Research approach: When studying PhI p 12 prevalence, researchers typically employ specific IgE detection against purified allergen components. In one methodological example, investigators detected specific IgE antibodies against Phl p 1, Phl p 5, Phl p 7, and Phl p 12 in a cohort of 130 Phleum-allergic subjects (82 children, 48 adults) .

What experimental designs are optimal for investigating T-cell responses to PhI p 12?

Researchers studying T-cell responses to PhI p 12 should consider these methodological approaches:

• Subject selection parameters:

  • Include grass pollen-allergic subjects with confirmed IgE sensitization to profilin

  • Consider both pediatric and adult populations, as research suggests potential differences in response patterns

  • Document geographical origin of subjects due to regional variation in sensitization

• Release dynamics consideration: PhI p 12 and Phl p 1 are released from pollen simultaneously and in similar quantities, which has important implications for experimental design when using natural pollen extracts versus purified allergens .

• Analytical methods:

  • Employ mass spectrometry and immunochemistry to confirm allergen release from pollen

  • Use peripheral blood mononuclear cells (PBMCs) for in vitro T-cell response assays

  • Include a panel of profilins (e.g., Phl p 12, Ole e 2, Bet v 2, Mal d 4) when studying cross-reactivity

• Animal model considerations: Different mouse strains (e.g., BALB/c and C3H) should be employed to account for genetic factors influencing immune responses, particularly MHC II variations .

How can researchers effectively map epitopes in PhI p 12?

Multiple approaches are necessary for comprehensive epitope mapping of PhI p 12:

• B-cell epitope identification strategies:

  • Employ peptide microarrays with overlapping sequences

  • Consider phage display technology for conformational epitope mapping

  • Analyze surface-exposed regions through structural modeling

• T-cell epitope mapping methods:

  • Synthesize overlapping peptides spanning the PhI p 12 sequence

  • Test peptide capacity to stimulate T-cell proliferation or cytokine production

  • Note that research has identified two immunodominant epitope regions in PhI p 12

• Cross-reactivity epitope analysis:

  • The actin-binding site and adjacent plant-specific pocket comprise major immunogenic regions

  • Two regions overlapping with the actin-binding site have been identified as major cross-reactive epitopes

  • Research indicates residues 30-50 likely contribute significantly to extensive cross-reactivity in birch profilin

• Combined approaches:

  • Integrate computational prediction with experimental validation

  • Correlate epitope conservation with observed cross-reactivity patterns

  • Consider both sequential and conformational epitopes in your analysis

What distinguishes the cross-reactivity patterns of PhI p 12 from other profilins?

Understanding the cross-reactivity patterns of PhI p 12 requires a multifaceted approach:

Table based on data from search result

• Structural determinants: The actin-binding site and adjacent plant-specific pocket comprise key immunogenic regions responsible for cross-reactivity, with certain epitope regions covering most of the protein surface .

• Experimental approaches to differentiate cross-reactivity:

  • Employ competitive inhibition assays with purified profilins

  • Use recombinant allergen components for specific IgE testing

  • Conduct T-cell proliferation assays with various profilins to assess cross-reactivity at cellular level

How significant are T-cell responses to PhI p 12 in allergic disease progression?

Recent research has challenged traditional assumptions about PhI p 12 as a minor allergen:

• Comparable response to major allergens: Studies demonstrate that both T-cell response frequency (17/26 donors) and strength were comparable between PhI p 12 and the major allergen Phl p 1 .

• Role in clinical manifestations: T-cell responses to PhI p 12 play an important role in the development of allergic symptoms, particularly those associated with pollen-food syndrome .

• Mechanistic implications:

  • T-cell cross-reactivity to other profilins correlates with sequence homology

  • Conserved T-cell epitopes likely contribute to broad allergic sensitization

  • The simultaneous release of PhI p 12 and major allergens from pollen creates concurrent sensitization opportunities

• Clinical significance: Understanding PhI p 12 T-cell dynamics may explain why some patients with apparently minor allergen sensitization develop significant clinical symptoms, including severe forms of pollen-food syndrome .

What genetic factors influence immune responses to PhI p 12?

Several genetic determinants shape individual and population-level responses to PhI p 12:

• MHC II influence: Research in mouse models demonstrates that cross-reactivity to Bet v 2 in mice immunized with PhI p 12 is "mediated by conserved epitopes and further influenced by additional genetic factors, likely to be MHC II" .

• Mouse strain variation: Studies employing different mouse strains (BALB/c and C3H) reveal genetic background effects on immune response patterns, likely reflecting different MHC haplotypes that influence epitope recognition .

• Human population differences: The significant variation in profilin sensitization rates across Europe (5-51%) suggests genetic differences may contribute to regional sensitization patterns, though environmental exposure remains a critical factor .

• Research implications:

  • Include diverse genetic backgrounds in study populations

  • Consider HLA typing when analyzing T-cell response patterns

  • Analyze epitope binding predictions across common HLA variants

What approaches should researchers consider for developing PhI p 12-specific diagnostic tools?

Developing accurate diagnostic tools for PhI p 12 sensitization presents several methodological challenges:

• Distinguishing sensitization from cross-reactivity:

  • Employ component-resolved diagnostics with purified allergens

  • Conduct inhibition assays to determine primary sensitizing allergen

  • Consider regional sensitization patterns in result interpretation

• Sequence-based marker identification:

  • Identify unique sequence regions that differentiate PhI p 12 from other profilins

  • Develop peptide-based assays targeting PhI p 12-specific epitopes

  • Correlate sequence conservation with clinical cross-reactivity patterns

• Combined diagnostic approaches:

  • Integrate specific IgE measurement with functional assays

  • Consider basophil activation tests for biological relevance

  • Incorporate T-cell response assays for comprehensive assessment

• Clinical correlation considerations:

  • Document relationship between sensitization patterns and specific clinical manifestations

  • Differentiate between pollen-allergic and food-allergic phenotypes

  • Account for geographical variation in sensitization prevalence